Kestra Medical Technologies Inc(KMTS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KMTS Kestra Medical Technologies Inc

交易中 12-12 12:44:47 EST

26.56

+1.65

+6.62%

最高27.18	最低24.32	成交量19.73万
今开26.45	昨收24.91	日振幅11.48%
总市值15.50亿	流通市值8.16亿	总股本5,835万
成交额514.89万	换手率0.64%	流通股本3,074万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"KMTS","market":"US","secType":"STK","nameCN":"Kestra Medical Technologies Inc","latestPrice":26.56,"timestamp":1765561485100,"preClose":24.91,"halted":0,"volume":197275,"delay":0,"floatShares":30737300,"shares":58349053,"eps":-3.998144,"marketStatus":"交易中","change":1.65,"latestTime":"12-12 12:44:47 EST","open":26.45,"high":27.18,"low":24.32,"amount":5148917.744100001,"amplitude":0.114813,"askPrice":26.66,"askSize":20,"bidPrice":26.37,"bidSize":3,"shortable":3,"etf":0,"ttmEps":-3.998144,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765573200000},"marketStatusCode":2,"adr":0,"listingDate":1741237200000,"exchange":"NASDAQ","adjPreClose":24.91,"preHourTrading":{"tag":"盘前","latestPrice":26.7279,"preClose":24.91,"latestTime":"09:10 EST","volume":1055,"amount":27302.141385,"timestamp":1765548615978},"postHourTrading":{"tag":"盘后","latestPrice":24.5,"preClose":24.91,"latestTime":"19:55 EST","volume":19905,"amount":474074.356,"timestamp":1765500903159},"volumeRatio":1.322087},"requestUrl":"/m/hq/s/KMTS/wiki","defaultTab":"wiki","newsList":[{"id":"1138955769","title":"异动解读 | Kestra Medical Technologies盘中大涨8.34%，因增发600万股定价23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1138955769","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138955769?lang=zh_cn&edition=full","pubTime":"2025-12-03 22:36","pubTimestamp":1764772600,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies Inc（股票代码：KMTS）今日盘中大涨8.34%，引起了市场的广泛关注。消息面上，公司昨日宣布增发600万股普通股的承销公开发行定价为每股23.00美元。这一举措被市场解读为对公司未来发展的信心，从而推动了股价的上涨。增发所得资金将用于业务发展、增聘销售代表、研发投入以及营运资金等用途，进一步增强了投资者对公司的乐观预期。此次增发的定价和规模反映了市场对Kestra Medical Technologies价值的认可，投资者对公司未来的增长潜力持积极态度，带动了股价的强劲表现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["KMTS"],"gpt_icon":0},{"id":"1141029470","title":"异动解读 | Kestra Medical Technologies盘前大涨5.22%，因宣布增发600万股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1141029470","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141029470?lang=zh_cn&edition=full","pubTime":"2025-12-03 21:46","pubTimestamp":1764769598,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies Inc (KMTS)今日盘前股价大涨5.22%，引起了市场的广泛关注。消息面上，公司宣布增发600万股普通股的承销公开发行定价为每股23.00美元。这一举措可能被市场解读为积极的信号，投资者可能对公司未来的资金用途和增长潜力持乐观态度。此次增发的定价和规模表明公司正在筹集资金以支持其业务发展或战略计划，市场对此反应积极，推动了股价的上涨。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["KMTS"],"gpt_icon":0},{"id":"1117037000","title":"异动解读 | Kestra Medical Technologies盘前大涨5.22%，因增发600万股定价23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1117037000","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117037000?lang=zh_cn&edition=full","pubTime":"2025-12-03 21:46","pubTimestamp":1764769594,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies Inc（股票代码：KMTS）今日盘前股价大涨5.22%，引起了市场的广泛关注。消息面上，公司昨日宣布增发600万股普通股的承销公开发行定价为每股23.00美元。这一举措可能被市场解读为对公司未来发展的信心，从而推动了股价的上涨。公开增发通常意味着公司有新的资金需求或扩张计划，而定价的确定往往反映了市场对公司价值的认可。此次增发的定价和规模可能增强了投资者对Kestra Medical Technologies未来增长的预期，进而带动了股价的积极反应。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["KMTS"],"gpt_icon":0},{"id":"1100069600","title":"Kestra：增发600万股普通股的承销公开发行定价为每股23.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1100069600","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100069600?lang=zh_cn&edition=full","pubTime":"2025-12-03 11:14","pubTimestamp":1764731649,"startTime":"0","endTime":"0","summary":"Kestra：增发600万股普通股的承销公开发行定价为每股23.00美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","KMTS"],"gpt_icon":0},{"id":"2586441022","title":"Kestra Medical Technologies, Ltd.盘中异动 早盘股价大涨5.37%报27.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586441022","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586441022?lang=zh_cn&edition=full","pubTime":"2025-11-24 23:55","pubTimestamp":1763999743,"startTime":"0","endTime":"0","summary":"北京时间2025年11月24日23时55分，Kestra Medical Technologies, Ltd.股票出现波动，股价快速拉升5.37%。截至发稿，该股报27.49美元/股，成交量6.1261万股，换手率0.12%，振幅6.69%。Kestra Medical Technologies, Ltd.股票所在的医疗设备行业中，整体涨幅为0.46%。Kestra Medical Technologies, Ltd.公司简介：Kestra Medical Technologies Ltd是一家处于商业阶段的可穿戴医疗设备和数字医疗公司，专注于通过直观、智能和互联的监测和治疗干预技术改变心血管疾病患者的预后。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124235543977cc927&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124235543977cc927&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SCA","KMTS","BK4082"],"gpt_icon":0},{"id":"1183811261","title":"可穿戴除颤器最大规模实地研究证实Kestra的Assure设备具有强效性和安全性表现","url":"https://stock-news.laohu8.com/highlight/detail?id=1183811261","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183811261?lang=zh_cn&edition=full","pubTime":"2025-11-10 22:52","pubTimestamp":1762786334,"startTime":"0","endTime":"0","summary":"可穿戴除颤器最大规模实地研究证实Kestra的Assure设备具有强效性和安全性表现","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","KMTS"],"gpt_icon":0},{"id":"1137168375","title":"Kestra Medical Technologies Inc任命Timothy Moran为首席商务官，强化领导团队助力下一阶段发展","url":"https://stock-news.laohu8.com/highlight/detail?id=1137168375","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137168375?lang=zh_cn&edition=full","pubTime":"2025-10-07 20:03","pubTimestamp":1759838627,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies Inc任命Timothy Moran为首席商务官，强化领导团队助力下一阶段发展","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","KMTS"],"gpt_icon":0},{"id":"2552517170","title":"Kestra Medical Technologies, Ltd.2025财年实现净利润-1.14亿美元，同比减少21.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552517170","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552517170?lang=zh_cn&edition=full","pubTime":"2025-07-17 12:00","pubTimestamp":1752724819,"startTime":"0","endTime":"0","summary":"7月17日，Kestra Medical Technologies, Ltd.公布财报，公告显示公司2025财年净利润为-1.14亿美元，同比减少21.12%；其中营业收入为59.82百万美元，同比增加115.10%，每股基本收益为-2.46美元。从资产负债表来看，Kestra Medical Technologies, Ltd.总负债90.34百万美元，其中短期债务187000.00美元，资产负债比为0.04，流动比率为0.07。机构评级：截至2025年7月17日，当前有6家机构对Kestra Medical Technologies, Ltd.目标价做出预测，其中目标均价为26.83美元，其中最低目标价为20.00美元，最高目标价为30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717120025a4501456&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717120025a4501456&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KMTS"],"gpt_icon":0},{"id":"1121676116","title":"异动解读 | Kestra Medical Technologies盘后大跌6.05%，季度亏损远超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1121676116","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121676116?lang=zh_cn&edition=full","pubTime":"2025-07-16 06:18","pubTimestamp":1752617904,"startTime":"0","endTime":"0","summary":"医疗技术公司Kestra Medical Technologies Inc今日盘后股价大跌6.05%，主要原因是公司公布的季度财报显示亏损远超分析师预期。根据公司发布的财报，截至4月30日的季度中，Kestra Medical Technologies调整后每股亏损高达2.21美元，远远超过华尔街分析师平均预期的0.52美元亏损。公司本季度净亏损达到5440万美元，这一结果令投资者感到失望。尽管季度业绩不佳导致股价下跌，但华尔街分析师对Kestra Medical Technologies的长期前景仍保持谨慎乐观。然而，投资者仍需密切关注公司未来的盈利能力改善情况。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["KMTS"],"gpt_icon":0},{"id":"1105604618","title":"异动解读 | 科斯特拉医疗科技发布强劲财报，股价盘中大涨5.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=1105604618","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105604618?lang=zh_cn&edition=full","pubTime":"2025-07-16 04:06","pubTimestamp":1752609990,"startTime":"0","endTime":"0","summary":"可穿戴医疗设备制造商科斯特拉医疗科技今日盘中股价大涨5.64%，引起市场广泛关注。此次股价上涨主要受该公司发布的2025财年第四季度及全年财报利好消息推动。更值得注意的是，公司毛利率实现了显著提升，第四季度毛利率达到44.3%，较去年同期的13.9%大幅提高；全年毛利率提升至40.5%，相比去年的1.3%实现了跨越式增长。医生群体认知度的提升与患者的积极反馈形成了良性循环，再加上商业模式固有的规模效应，共同推动了毛利率的显著改善。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["KMTS"],"gpt_icon":0},{"id":"2517174835","title":"可穿戴心脏设备制造商Kestra Medical(KMTS.US)IPO定价17美元/股 上市首日涨逾28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517174835","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517174835?lang=zh_cn&edition=full","pubTime":"2025-03-07 16:02","pubTimestamp":1741334561,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，可穿戴心脏设备制造商Kestra Medical Technologies以每股17美元的价格发行1190万股股票，高于14 - 16美元的发行价区间，筹资2.02亿美元。Kestra于3月6日(周四)登陆纳斯达克，上市首日收涨28.47%。Kestra正在商业化其心脏康复系统平台，这是一个综合且先进的系统，将监测、治疗、数字健康和患者支持服务整合为一个统一的解决方案。截至2025年1月31日，Kestra的系统已被美国550多家医院积极采用，自2022年8月全面商业化以来，已有超过1.7万名患者使用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1259007.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["KMTS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kestramedical.com","stockEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":-0.0962},{"period":"3month","weight":0.1411},{"period":"6month","weight":0.4145},{"period":"1year","weight":0.4653},{"period":"ytd","weight":0.4653}],"compareEarnings":[{"period":"1week","weight":0.007},{"period":"1month","weight":0.009},{"period":"3month","weight":0.0483},{"period":"6month","weight":0.1544},{"period":"1year","weight":0.1345},{"period":"ytd","weight":0.1759}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kestra Medical Technologies, Ltd.是一家于2021年5月20日根据百慕大法律注册成立的豁免股份有限公司。该公司是一家商业阶段、可穿戴医疗设备和数字医疗保健公司，专注于使用直观、智能和互联的监测和治疗干预技术改变心血管疾病患者的预后。该公司已经开发并正在商业化他们的心脏恢复系统平台，这是一个综合和先进的系统，将监测、治疗、数字健康和患者支持服务整合为一个单一、统一的解决方案。","exchange":"NASDAQ","name":"Kestra Medical Technologies Inc","nameEN":"Kestra Medical Technologies Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kestra Medical Technologies Inc(KMTS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kestra Medical Technologies Inc(KMTS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kestra Medical Technologies Inc,KMTS,Kestra Medical Technologies Inc股票,Kestra Medical Technologies Inc股票老虎,Kestra Medical Technologies Inc股票老虎国际,Kestra Medical Technologies Inc行情,Kestra Medical Technologies Inc股票行情,Kestra Medical Technologies Inc股价,Kestra Medical Technologies Inc股市,Kestra Medical Technologies Inc股票价格,Kestra Medical Technologies Inc股票交易,Kestra Medical Technologies Inc股票购买,Kestra Medical Technologies Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kestra Medical Technologies Inc(KMTS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kestra Medical Technologies Inc(KMTS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}